tiprankstipranks
Trending News
More News >
Faes Farma SA (GB:0K9H)
LSE:0K9H
Advertisement

Faes Farma (0K9H) Price & Analysis

Compare
2 Followers

0K9H Stock Chart & Stats

€4.71
€0.02(0.63%)
At close: 4:00 PM EST
€4.71
€0.02(0.63%)

Faes Farma News

0K9H FAQ

What was Faes Farma SA’s price range in the past 12 months?
Faes Farma SA lowest share price was €3.27 and its highest was €4.83 in the past 12 months.
    What is Faes Farma SA’s market cap?
    Faes Farma SA’s market cap is €1.46B.
      When is Faes Farma SA’s upcoming earnings report date?
      Faes Farma SA’s upcoming earnings report date is Feb 27, 2026 which is in 81 days.
        How were Faes Farma SA’s earnings last quarter?
        Currently, no data Available
        Is Faes Farma SA overvalued?
        According to Wall Street analysts Faes Farma SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Faes Farma SA pay dividends?
          Faes Farma SA does not currently pay dividends.
          What is Faes Farma SA’s EPS estimate?
          Faes Farma SA’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Faes Farma SA have?
          Faes Farma SA has 316,223,940 shares outstanding.
            What happened to Faes Farma SA’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Faes Farma SA?
            Currently, no hedge funds are holding shares in GB:0K9H

            Faes Farma Stock Smart Score

            5
            Neutral
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Positive
            20 days / 200 days
            Momentum
            39.48%
            12-Months-Change

            Fundamentals

            Return on Equity
            14.89%
            Trailing 12-Months
            Asset Growth
            19.41%
            Trailing 12-Months

            Company Description

            Faes Farma SA

            Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan, a citicoline; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. It also exports its products. Faes Farma, S.A. was founded in 1933 and is headquartered in Leioa, Spain.

            Faes Farma (0K9H) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Almirall
            Grifols
            LABORATORIO REIG JOFRE
            Laboratorios Farmaceuticos Rovi
            Pharma Mar SA

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis